Gabriel NicolasContreras Martin University of Miami Miller School of MedicineUnited States

I, Gabriel Contreras, MD, MPH, earned my medical degree in 1984 from the Autonomous University of Guadalajara in Mexico. I trained in Internal medicine, nephrology, hypertension, critical care, and earned a degree as Master in Public Health between 1989 and 2003. In 1996, I joined the School of Medicine at the University of Miami. During my time as faculty in the Department of Medicine, I have been involved in the development and establishment of a successful clinical research program in the Division of Nephrology. I have an ongoing commitment to improving kidney disease outcomes among racial and ethnic minorities throughout the clinical research program at the University of Miami, Miller School of Medicine.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Precise Phenotyping and Treatment HeatherReich Chairperson Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comSanatorio Parque SAArgentina Deciphering the IGAN Cell Atlas JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Complement-mediated Kidney Diseases in the Era of Complement Inhibitors MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly CART-T Cell for Refractory Lupus JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio New Targets to Reduce the Burden of Rare Kidney Diseases LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States Q and A Hall C4
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Insights From Understanding Heterogeneous Trajectories to Kidney Failure FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina Magdalena Madero Chairperson madero.magdalena@gmail.comChief of Nephrology, Instituto Nacional de CardiolMexico PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States Understanding the Heterogeneous Trajectory of CKD MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States Review of Medical Therapies Proven to Delay CKD Progression DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom Impact of Obesity and Novel Treatment Strategies on CKD Progression PeterRossing Speaker peter.rossing@regionh.dkSteno Diabetes Center Copenhagen Denmark Q and A Hall C4	Hypertension - the Cutting Edge: Advances in Science and Management TaraChang Chairperson tichang@stanford.eduStanford UniversityUnited States Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina) Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension GerardoGamba Speaker gamba@biomedicas.unam.mxUniversidad Nacional Autónoma de MéxicoMexico Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension? TaliElfassy Speaker t.elfassy@med.miami.eduUnited States State-of-the-Art Treatment of Hypertension in Pediatrics With CKD RahulChanchlani Speaker chanchlr@mcmaster.caMcMaster Children's Hospital, Hamilton, CanadaCanada State-of-the-Art Treatment of Hypertension in Adults With CKD SusanneNicholas Speaker sunicholas@mednet.ucla.eduDavid Geffen School of Medicine at UCLAUnited States Q and A Hall D
4:30 p.m. 5:30 p.m.	Personalized Kidney Replacement Treatment: Adapting Guidelines to Real-world Scenarios Annie-ClaireNadeau-Fredette Chairperson annieclairenaf@gmail.comUniversité de MontréalCanada Gabriel NicolasContreras Martin Chairperson gcontrer@med.miami.eduUniversity of Miami Miller School of MedicineUnited States Maria ElenaBiain Chairperson mariaelenabiain@yahoo.com.arMédica Nefróloga The Who, What, Where, When and Why of Incremental Hemodialysis ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States The Changing Landscape of Home Hemodialysis: Is There a Right Patient for Home Hemodialysis? KarthikTennankore Speaker ktennankore@gmail.comNova Scotia Health/Dalhousie UniversityCanada Patient-, Center- and Country-related Risk Factors for Peritoneal Dialysis Attrition: Can We Prevent It? RosileneM Elias Speaker rosilenemotta@hotmail.comUniversidade de Sao PauloBrazil Q and A Hall C4

Day 3 - Tuesday April 16, 2024

Time	Session

11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) AlessiaFornoni Chairperson afornoni@med.miami.eduUnited States Prof LizLightstone Chairperson l.lightstone@imperial.ac.ukImperial College LondonUnited Kingdom MasaomiNangaku Chairperson mnangaku@m.u-tokyo.ac.jpJapan Acceptance Speech: Bywaters Award MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpKyoto UniversityJapan Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly ELP2 Graduation MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Hall A